Agilent Technologies, Inc. (A): Cost of Revenue
$3.31B
Year ended 2025-10-31
$3.40B
Trailing 12 months to 2026-07-31
+1.9%
3-year compound annual growth
+5.7%
5-year compound annual growth
+5.2%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-10-31 | $3.31B | +11.1% | 2025-12-22, From 2024-11-01 |
| 2024-10-31 | $2.98B | -11.7% | 2025-12-22, From 2023-11-01 |
| 2023-10-31 | $3.37B | +7.7% | 2025-12-22, From 2022-11-01 |
| 2022-10-31 | $3.13B | +7.3% | 2024-12-20, From 2021-11-01 |
| 2021-10-31 | $2.91B | +16.4% | 2023-12-20, From 2020-11-01 |
| 2020-10-31 | $2.50B | +6.1% | 2022-12-21, From 2019-11-01 |
| 2019-10-31 | $2.36B | +5.6% | 2021-12-17, From 2018-11-01 |
| 2018-10-31 | $2.23B | +7.8% | 2020-12-18, From 2017-11-01 |
| 2017-10-31 | $2.07B | +3.4% | 2019-12-19, From 2016-11-01 |
| 2016-10-31 | $2.00B | +0.4% | 2018-12-20, From 2015-11-01 |
| 2015-10-31 | $2.00B | -3.6% | 2017-12-21, From 2014-11-01 |
| 2014-10-31 | $2.07B | +4.3% | 2016-12-20, From 2013-11-01 |
| 2013-10-31 | $1.99B | n/c | 2015-12-21, From 2012-11-01 |
| 2012-10-31 | $3.25B | +5.4% | 2014-12-22, From 2011-11-01 |
| 2011-10-31 | $3.09B | +22.8% | 2013-12-19, From 2010-11-01 |
| 2010-10-31 | $2.51B | +14.8% | 2012-12-20, From 2009-11-01 |
| 2009-10-31 | $2.19B | -15.1% | 2011-12-16, From 2008-11-01 |
| 2008-10-31 | $2.58B | +5.2% | 2010-12-20, From 2007-11-01 |
| 2007-10-31 | $2.45B | n/a | 2009-12-21, From 2006-11-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Agilent Technologies, Inc. (A) | 2025-10-31 | $3.31B | +11.1% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $4.41B | -2.0% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $1.47B | -2.5% |
| Bruker Corp (BRKR) | 2025-12-31 | $1.86B | +8.3% |
| Waters Corp (WAT) | 2025-12-31 | $1.29B | +7.4% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $1.24B | +4.7% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $198.94M | +1.3% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $97.03M | +8.6% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $114.22M | -2.1% |
Compare A, AVTR, ILMN, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗